[(2S)-1-[(1R,3S,5R)-3-[7-[2-[2-[(1R,3S,5S)-2-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]-2-azabicyclo[3.1.0]hexan-3-yl]-4,5-dihydro-3H-benzo[e]benzimidazol-7-yl]ethynyl]-4,5-dihydro-3H-benzo[e]benzimidazol-2-yl]-2-azabicyclo[3.1.0]hexan-2-yl]-3-methyl-1-oxobutan-2-yl]-methylcarbamic acid

C48H54N8O6 — CID 67048180

IUPAC[(2S)-1-[(1R,3S,5R)-3-[7-[2-[2-[(1R,3S,5S)-2-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]-2-azabicyclo[3.1.0]hexan-3-yl]-4,5-dihydro-3H-benzo[e]benzimidazol-7-yl]ethynyl]-4,5-dihydro-3H-benzo[e]benzimidazol-2-yl]-2-azabicyclo[3.1.0]hexan-2-yl]-3-methyl-1-oxobutan-2-yl]-methylcarbamic acid
SMILESCOC(=O)N[C@H](C(=O)N1[C@@H]2C[C@H]2C[C@H]1c1nc2c([nH]1)CCc1cc(C#Cc3ccc4c(c3)CCc3[nH]c([C@@H]5C[C@H]6C[C@H]6N5C(=O)[C@H](C(C)C)N(C)C(=O)O)nc3-4)ccc1-2)C(C)C
InChIInChI=1S/C48H54N8O6/c1-23(2)39(53-47(59)62-6)45(57)55-35-19-29(35)21-37(55)43-49-33-15-11-27-17-25(9-13-31(27)40(33)51-43)7-8-26-10-14-32-28(18-26)12-16-34-41(32)52-44(50-34)38-22-30-20-36(30)56(38)46(58)42(24(3)4)54(5)48(60)61/h9-10,13-14,17-18,23-24,29-30,35-39,42H,11-12,15-16,19-22H2,1-6H3,(H,49,51)(H,50,52)(H,53,59)(H,60,61)/t29-,30+,35+,36+,37-,38-,39-,42-/m0/s1
InChIKeyFNLIGUWMHLTYRO-WWSJVEEXSA-N
MW839.01 g/mol
LogP6.40
Rot. Bonds8

About [(2S)-1-[(1R,3S,5R)-3-[7-[2-[2-[(1R,3S,5S)-2-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]-2-azabicyclo[3.1.0]hexan-3-yl]-4,5-dihydro-3H-benzo[e]benzimidazol-7-yl]ethynyl]-4,5-dihydro-3H-benzo[e]benzimidazol-2-yl]-2-azabicyclo[3.1.0]hexan-2-yl]-3-methyl-1-oxobutan-2-yl]-methylcarbamic acid

[(2S)-1-[(1R,3S,5R)-3-[7-[2-[2-[(1R,3S,5S)-2-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]-2-azabicyclo[3.1.0]hexan-3-yl]-4,5-dihydro-3H-benzo[e]benzimidazol-7-yl]ethynyl]-4,5-dihydro-3H-benzo[e]benzimidazol-2-yl]-2-azabicyclo[3.1.0]hexan-2-yl]-3-methyl-1-oxobutan-2-yl]-methylcarbamic acid (PubChem CID 67048180) has the molecular formula C48H54N8O6 and a molecular weight of 839.01 g/mol. Its IUPAC name is [(2S)-1-[(1R,3S,5R)-3-[7-[2-[2-[(1R,3S,5S)-2-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]-2-azabicyclo[3.1.0]hexan-3-yl]-4,5-dihydro-3H-benzo[e]benzimidazol-7-yl]ethynyl]-4,5-dihydro-3H-benzo[e]benzimidazol-2-yl]-2-azabicyclo[3.1.0]hexan-2-yl]-3-methyl-1-oxobutan-2-yl]-methylcarbamic acid.

Molecular Properties

Compound Name[(2S)-1-[(1R,3S,5R)-3-[7-[2-[2-[(1R,3S,5S)-2-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]-2-azabicyclo[3.1.0]hexan-3-yl]-4,5-dihydro-3H-benzo[e]benzimidazol-7-yl]ethynyl]-4,5-dihydro-3H-benzo[e]benzimidazol-2-yl]-2-azabicyclo[3.1.0]hexan-2-yl]-3-methyl-1-oxobutan-2-yl]-methylcarbamic acid
PubChem CID67048180
Molecular FormulaC48H54N8O6
Molecular Weight839.01 g/mol
Exact Mass838.42
IUPAC Name[(2S)-1-[(1R,3S,5R)-3-[7-[2-[2-[(1R,3S,5S)-2-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]-2-azabicyclo[3.1.0]hexan-3-yl]-4,5-dihydro-3H-benzo[e]benzimidazol-7-yl]ethynyl]-4,5-dihydro-3H-benzo[e]benzimidazol-2-yl]-2-azabicyclo[3.1.0]hexan-2-yl]-3-methyl-1-oxobutan-2-yl]-methylcarbamic acid
SMILESCOC(=O)N[C@H](C(=O)N1[C@@H]2C[C@H]2C[C@H]1c1nc2c([nH]1)CCc1cc(C#Cc3ccc4c(c3)CCc3[nH]c([C@@H]5C[C@H]6C[C@H]6N5C(=O)[C@H](C(C)C)N(C)C(=O)O)nc3-4)ccc1-2)C(C)C
InChIInChI=1S/C48H54N8O6/c1-23(2)39(53-47(59)62-6)45(57)55-35-19-29(35)21-37(55)43-49-33-15-11-27-17-25(9-13-31(27)40(33)51-43)7-8-26-10-14-32-28(18-26)12-16-34-41(32)52-44(50-34)38-22-30-20-36(30)56(38)46(58)42(24(3)4)54(5)48(60)61/h9-10,13-14,17-18,23-24,29-30,35-39,42H,11-12,15-16,19-22H2,1-6H3,(H,49,51)(H,50,52)(H,53,59)(H,60,61)/t29-,30+,35+,36+,37-,38-,39-,42-/m0/s1
InChIKeyFNLIGUWMHLTYRO-WWSJVEEXSA-N
XLogP6.40
TPSA176.85 Ų
H-Bond Donors4
H-Bond Acceptors7
Rotatable Bonds8
Heavy Atoms62
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500839.01
LogP ≤ 56.40
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 107

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'triple_bond', 'substructure': 'N/A'}

Analyze [(2S)-1-[(1R,3S,5R)-3-[7-[2-[2-[(1R,3S,5S)-2-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]-2-azabicyclo[3.1.0]hexan-3-yl]-4,5-dihydro-3H-benzo[e]benzimidazol-7-yl]ethynyl]-4,5-dihydro-3H-benzo[e]benzimidazol-2-yl]-2-azabicyclo[3.1.0]hexan-2-yl]-3-methyl-1-oxobutan-2-yl]-methylcarbamic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [(2S)-1-[(1R,3S,5R)-3-[7-[2-[2-[(1R,3S,5S)-2-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]-2-azabicyclo[3.1.0]hexan-3-yl]-4,5-dihydro-3H-benzo[e]benzimidazol-7-yl]ethynyl]-4,5-dihydro-3H-benzo[e]benzimidazol-2-yl]-2-azabicyclo[3.1.0]hexan-2-yl]-3-methyl-1-oxobutan-2-yl]-methylcarbamic acid?
The IUPAC name of [(2S)-1-[(1R,3S,5R)-3-[7-[2-[2-[(1R,3S,5S)-2-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]-2-azabicyclo[3.1.0]hexan-3-yl]-4,5-dihydro-3H-benzo[e]benzimidazol-7-yl]ethynyl]-4,5-dihydro-3H-benzo[e]benzimidazol-2-yl]-2-azabicyclo[3.1.0]hexan-2-yl]-3-methyl-1-oxobutan-2-yl]-methylcarbamic acid (CID 67048180) is [(2S)-1-[(1R,3S,5R)-3-[7-[2-[2-[(1R,3S,5S)-2-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]-2-azabicyclo[3.1.0]hexan-3-yl]-4,5-dihydro-3H-benzo[e]benzimidazol-7-yl]ethynyl]-4,5-dihydro-3H-benzo[e]benzimidazol-2-yl]-2-azabicyclo[3.1.0]hexan-2-yl]-3-methyl-1-oxobutan-2-yl]-methylcarbamic acid.
What is the SMILES notation for [(2S)-1-[(1R,3S,5R)-3-[7-[2-[2-[(1R,3S,5S)-2-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]-2-azabicyclo[3.1.0]hexan-3-yl]-4,5-dihydro-3H-benzo[e]benzimidazol-7-yl]ethynyl]-4,5-dihydro-3H-benzo[e]benzimidazol-2-yl]-2-azabicyclo[3.1.0]hexan-2-yl]-3-methyl-1-oxobutan-2-yl]-methylcarbamic acid?
The canonical SMILES for [(2S)-1-[(1R,3S,5R)-3-[7-[2-[2-[(1R,3S,5S)-2-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]-2-azabicyclo[3.1.0]hexan-3-yl]-4,5-dihydro-3H-benzo[e]benzimidazol-7-yl]ethynyl]-4,5-dihydro-3H-benzo[e]benzimidazol-2-yl]-2-azabicyclo[3.1.0]hexan-2-yl]-3-methyl-1-oxobutan-2-yl]-methylcarbamic acid is COC(=O)N[C@H](C(=O)N1[C@@H]2C[C@H]2C[C@H]1c1nc2c([nH]1)CCc1cc(C#Cc3ccc4c(c3)CCc3[nH]c([C@@H]5C[C@H]6C[C@H]6N5C(=O)[C@H](C(C)C)N(C)C(=O)O)nc3-4)ccc1-2)C(C)C.
What is the InChIKey of [(2S)-1-[(1R,3S,5R)-3-[7-[2-[2-[(1R,3S,5S)-2-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]-2-azabicyclo[3.1.0]hexan-3-yl]-4,5-dihydro-3H-benzo[e]benzimidazol-7-yl]ethynyl]-4,5-dihydro-3H-benzo[e]benzimidazol-2-yl]-2-azabicyclo[3.1.0]hexan-2-yl]-3-methyl-1-oxobutan-2-yl]-methylcarbamic acid?
The InChIKey is FNLIGUWMHLTYRO-WWSJVEEXSA-N. The full InChI is InChI=1S/C48H54N8O6/c1-23(2)39(53-47(59)62-6)45(57)55-35-19-29(35)21-37(55)43-49-33-15-11-27-17-25(9-13-31(27)40(33)51-43)7-8-26-10-14-32-28(18-26)12-16-34-41(32)52-44(50-34)38-22-30-20-36(30)56(38)46(58)42(24(3)4)54(5)48(60)61/h9-10,13-14,17-18,23-24,29-30,35-39,42H,11-12,15-16,19-22H2,1-6H3,(H,49,51)(H,50,52)(H,53,59)(H,60,61)/t29-,30+,35+,36+,37-,38-,39-,42-/m0/s1.
What are the key properties of [(2S)-1-[(1R,3S,5R)-3-[7-[2-[2-[(1R,3S,5S)-2-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]-2-azabicyclo[3.1.0]hexan-3-yl]-4,5-dihydro-3H-benzo[e]benzimidazol-7-yl]ethynyl]-4,5-dihydro-3H-benzo[e]benzimidazol-2-yl]-2-azabicyclo[3.1.0]hexan-2-yl]-3-methyl-1-oxobutan-2-yl]-methylcarbamic acid?
[(2S)-1-[(1R,3S,5R)-3-[7-[2-[2-[(1R,3S,5S)-2-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]-2-azabicyclo[3.1.0]hexan-3-yl]-4,5-dihydro-3H-benzo[e]benzimidazol-7-yl]ethynyl]-4,5-dihydro-3H-benzo[e]benzimidazol-2-yl]-2-azabicyclo[3.1.0]hexan-2-yl]-3-methyl-1-oxobutan-2-yl]-methylcarbamic acid has a molecular weight of 839.01 g/mol, XLogP of 6.40, 8 rotatable bonds, 4 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for [(2S)-1-[(1R,3S,5R)-3-[7-[2-[2-[(1R,3S,5S)-2-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]-2-azabicyclo[3.1.0]hexan-3-yl]-4,5-dihydro-3H-benzo[e]benzimidazol-7-yl]ethynyl]-4,5-dihydro-3H-benzo[e]benzimidazol-2-yl]-2-azabicyclo[3.1.0]hexan-2-yl]-3-methyl-1-oxobutan-2-yl]-methylcarbamic acid is sourced from PubChem (CID 67048180), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).